Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in rats

BACKGROUND: Soluble amyloid-beta oligomers (Aβo) begin to accumulate in the human brain one to two decades before a clinical diagnosis of Alzheimer’s disease (AD). The literature supports that soluble Aβo are implicated in synapse and neuronal losses in the brain regions such as the hippocampus. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hector, Audrey, Provost, Chloé, Delignat-Lavaud, Benoît, Bouamira, Khadija, Menaouar, Chahinez-Anissa, Mongrain, Valérie, Brouillette, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571363/
https://www.ncbi.nlm.nih.gov/pubmed/37833786
http://dx.doi.org/10.1186/s13195-023-01316-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571363/
https://www.ncbi.nlm.nih.gov/pubmed/37833786
http://dx.doi.org/10.1186/s13195-023-01316-4

Ejemplares similares